<?xml version="1.0" encoding="UTF-8"?>
<p>Subsequent studies were performed mostly in patients with HCV-associated cryoglobulinemic vasculitis (many with kidney involvement) [
 <xref rid="B1-pathogens-08-00176" ref-type="bibr">1</xref>,
 <xref rid="B10-pathogens-08-00176" ref-type="bibr">10</xref>]. All the authors observed that the elimination of HCV RNA from serum after antiviral therapy gave improvement of clinical abnormalities (including renal disease). These reports gave emphasis to the fact that IFN-based therapies are less effective and more toxic in individuals with HCV-associated MCS in comparison with the general population infected with HCV.
</p>
